Protagonist Therapeutics Inc. (PTGX)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XMEX $
140. 91
+8.89
+6.7338%
$
8.44B Market Cap
- P/E Ratio
- Div Yield
519,100 Volume
0.75 Eps
$ 132.02
Previous Close 
Want to track PTGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Protagonist Therapeutics Inc. (PTGX) Statistics
Valuation metrics
Market Cap 8.44B
Enterprise value 8.88B
Trailing P/E (ttm) -78.2
Forward P/E -
PEG ratio 0.22
Price/Sales (ttm) 122.36
Price/Book (mrq) 13.99
Enterprise Value/Revenue 119.87
Enterprise Value/EBITDA -77.93
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.07M
Average volume (90 days) 653.19K
Price summary
52-Week low 50.48
52-Week high 141.1
Beta -
50-Day moving average 113.67
200-Day moving average 96.05
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.55%
Operating margin -1.92%
Operational effectiveness
Return on assets -0.16%
Return on equity -0.18%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.14
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.76
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.42
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 17.76%
Book value per share (mrq) 10.07
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
